CN Stock MarketDetailed Quotes
603439 Guizhou Sanli Pharmaceutical Co.,Ltd.
- 14.36
- -0.06-0.42%
Market Closed Dec 13 15:00 CST
5.88BMarket Cap17.88P/E (TTM)
14.60High14.33Low95.65KlotVolume14.41Open14.42Pre Close138.32MTurnover2.37%Turnover Ratio20.11P/E (Static)409.80MShares19.8652wk High3.67P/B5.80BFloat Cap10.6952wk Low15.86Limit Up403.84MShs Float43.55Historical High12.98Limit Down1.87%Amplitude8.27Historical Low0.20Dividend TTM14.46Avg Price47.34KlotAsk1.39%Div YieldTTM100Lot Size46.74KlotBid
Guizhou Sanli Pharmaceutical Co.,Ltd. Key Stats
EPS
According to the latest financial report of Guizhou Sanli Pharmaceutical Co.,Ltd., the latest earnings per share (TTM) for the company is 0.47. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Guizhou Sanli Pharmaceutical Co.,Ltd.'s latest financial report to see how much their book value per share (BVPS) is currently at 3.91.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Guizhou Sanli Pharmaceutical Co.,Ltd. shows that the company's current ratio is 1.99, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Guizhou Sanli Pharmaceutical Co.,Ltd., the quick ratio is 1.62, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Guizhou Sanli Pharmaceutical Co.,Ltd.? The latest ROE figure is 12.63%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Guizhou Sanli Pharmaceutical Co.,Ltd., the total asset return on investment (ROA) is 6.65%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Guizhou Sanli Pharmaceutical Co.,Ltd.'s latest financial report to see how their gross margin is doing - currently at 69.28%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Guizhou Sanli Pharmaceutical Co.,Ltd., the net profit margin is 13.74%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
